182 related articles for article (PubMed ID: 464378)
1. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
Tice AD; Solomon RJ
Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Wallace RJ; Swenson JM; Silcox VA; Bullen MG
J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
[TBL] [Abstract][Full Text] [Related]
3. Disseminated disease due to Mycobacterium chelonei treated with amikacin and cefoxitin. Absence of killing with either agent and possible role of granulocytes in clinical response.
Carpenter JL; Troxell M; Wallace RJ
Arch Intern Med; 1984 Oct; 144(10):2063-5. PubMed ID: 6486990
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
Wallace RJ; Jones DB; Wiss K
Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
Dalovisio JR; Pankey GA; Wallace RJ; Jones DB
Rev Infect Dis; 1981; 3(5):1068-74. PubMed ID: 7339806
[TBL] [Abstract][Full Text] [Related]
6. "Fish fanciers' finger": tropical fish-tank granuloma.
Hugh TB; Coleman MJ
Med J Aust; 1981 Jun; 1(12):614-5. PubMed ID: 6973062
[No Abstract] [Full Text] [Related]
7. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
[TBL] [Abstract][Full Text] [Related]
8. Co-trimoxazole and "fish fanciers' finger".
Light L
Med J Aust; 1982 Jul; 2(2):67. PubMed ID: 6214700
[No Abstract] [Full Text] [Related]
9. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
Arai H; Nakajima H; Kaminaga Y
J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to sulfadiazine, sulfisoxazole and sulfathiazole.
Casal M; Rodriguez F
Eur J Clin Microbiol; 1984 Aug; 3(4):320-1. PubMed ID: 6489322
[No Abstract] [Full Text] [Related]
11. In vitro activity of trimethoprim and sulfamethoxazole against the nontuberculous mycobacteria.
Wallace RJ; Wiss K; Bushby MB; Hollowell DC
Rev Infect Dis; 1982; 4(2):326-31. PubMed ID: 7111959
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium fortuitum lung abscess: resolution with prolonged trimethoprim/sulfamethoxazole therapy.
Pacht ER
Am Rev Respir Dis; 1990 Jun; 141(6):1599-601. PubMed ID: 2350102
[TBL] [Abstract][Full Text] [Related]
13. Treatment of nocardial infection with trimethoprim and sulfamethoxazole.
Maderazo EG; Quintiliani R
Am J Med; 1974 Oct; 57(4):671-5. PubMed ID: 4611207
[No Abstract] [Full Text] [Related]
14. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii.
Ahn CH; Wallace RJ; Steele LC; Murphy DT
Am Rev Respir Dis; 1987 Jan; 135(1):10-6. PubMed ID: 3800137
[TBL] [Abstract][Full Text] [Related]
15. [Experimental infections caused by atypical mycobacteria. 6. Experimental Mycobacterium fortuitum infection and trial chemotherapy].
Kuze F; Lee Y; Maekawa N; Suzuki Y
Kekkaku; 1983 Jul; 58(7):385-93. PubMed ID: 6656072
[No Abstract] [Full Text] [Related]
16. [Sporotrichoid cutaneous infection caused by Mycobacterium chelonei. Cure with minocycline].
Godard W; Cordier N; Kazmierczak A; Lambert D
Presse Med; 1986 Jan; 15(3):120. PubMed ID: 2937044
[No Abstract] [Full Text] [Related]
17. Skin granulomas due to Mycobacterium gordonae.
Gengoux P; Portaels F; Lachapelle JM; Minnikin DE; Tennstedt D; Tamigneau P
Int J Dermatol; 1987 Apr; 26(3):181-4. PubMed ID: 3570593
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cutaneous infection due to Mycobacterium ulcerans.
Song M; Vincke G; Vanachter H; Benekens J; Achten G
Dermatologica; 1985; 171(3):197-9. PubMed ID: 2416603
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary mycobacteriosis due to Mycobacterium xenopi" in-vitro sensitivity to classical antitubercular agents and clinical development].
Baugnée PE; Pouthier F; Delaunois L
Acta Clin Belg; 1996; 51(1):19-27. PubMed ID: 8669159
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium chelonei and abscess formation in soft tissues.
Hanson PJ; Thomas JM; Collins JV
Tubercle; 1987 Dec; 68(4):297-9. PubMed ID: 3455569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
